Preclinical Safety, Biodistribution, and Tumor Infiltration Analysis of CAR-T Cell Targets Using in situ Hybridization Technology
19 Jun 2019Chimeric antigen receptor (CAR) T cell therapy has proven to be highly effective in treating hematologic malignancies, and major efforts are being made to achieve similar efficacy in solid tumors. This poster evaluates a method for tracking and monitoring CAR+ T cells within the context of intact tissue and tumor to understand the mechanisms underlying off-tumor toxicity and efficacy in tumor killing.
Related Products
Request Quote for All Products
RNAscope™ Technology
Advanced Cell DiagnosticsIndependent of your genes of interest, thes easy RNA in situ hybridization assays use common reagents and protocols; providing universal assay conditions. All RNA-ISH kits contain reagents in a convenient ready-to-use (RTU) format, and chromogenic dyes are available to interrogate a single or two genes simultaneously. Most versatile are the RNAscope Multiplex Fluorescent Reagent Kits, enabling you to interrogate 1, 2 or 3 genes simultaneously.